PH
Insider
P. Kent Hawryluk
President & CEOP. Kent Hawryluk (President & CEO) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in MBX. Across 2 priced purchase filings, the average 21-session return was +55.1% from execution and +43.3% from disclosure (delay-adjusted; derived). The largest single filing was $526K of MBX (18,500 sh × $28.41, as filed), executed Mar 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+55.1%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+43.3%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$798K
shares × price, as filed
Last traded
Mar 13
Filed Mar 16
Volume by month
Buys $1.3M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
MBX
MBX
MBX · 3 buys · 0 sells
3 filings
Recent filings
MBXPURCHASE
MBX Biosciences, Inc.
View filing →
$526K18,500 sh × $28.41
Exec Mar 13
Filed Mar 16 · 8:02 AM ET MBXPURCHASE MBX Biosciences, Inc. View filing → $273K
20,000 sh × $13.64
Exec Oct 20 2025
Filed Oct 21 2025 · 5:43 PM ET MBXPURCHASE MBX Biosciences, Inc. View filing → $534K
50,000 sh × $10.69
Exec Feb 4 2025
Filed Feb 5 2025 · 5:30 PM ET